Taiwan's medical device industry is facing increasing pressure from China's red supply chain. With the rising import value of Chinese-made medical devices, Taiwan's market is at risk of being overtaken by lower-cost competitors.
 
As Taiwan’s industry faces this challenge, many experts are calling for stronger protectionist policies, urging the promotion of "Made in Taiwan" medical devices for local use. The key question: Should Taiwanese companies focus on building strong brands or adopt a CDMO (Contract Development and Manufacturing Organization) model?
 
While domestic policies and strengthening local brands are crucial, getting these devices into hospitals and exporting internationally comes with its own set of complex hurdles.
 
In this issue, we dive deep into the blind spots of Taiwanese manufacturers and explore what strategies are needed to stay competitive in the global medical device market.
 
Stay informed on the latest challenges and solutions in Taiwan's medtech industry. Follow #Globalbio for more updates!
#MedicalDeviceInnovation #TaiwanMedTech #RedSupplyChain #MadeInTaiwan #GlobalHealthcare